Studies have demonstrated that IDO plays an indispensable role in allogenic MSC-mediated inhibition of T cell proliferation in lupus patients, which could be enhanced by IFN-γ (Wang et al., 2014). The gene discussed is IDO1; the disease is systemic lupus erythematosus.